User profiles for Gareth Hughes

Gareth Hughes

Caizio
Verified email at caizio.com
Cited by 20867

Nanostructure-mediated drug delivery

GA Hughes - Nanomedicine: nanotechnology, biology and medicine, 2005 - Elsevier
Nanotechnology is expected to have an impact on all industries including semiconductors,
manufacturing, and biotechnology. Tools that provide the capability to characterize and …

Episodic sexual transmission of HIV revealed by molecular phylodynamics

F Lewis, GJ Hughes, A Rambaut, A Pozniak… - PLoS …, 2008 - journals.plos.org
Background The structure of sexual contact networks plays a key role in the epidemiology of
sexually transmitted infections, and their reconstruction from interview data has provided …

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

…, JP Orme, MRV Finlay, RA Ward, MJ Mellor, G Hughes… - Cancer discovery, 2014 - AACR
First-generation EGFR tyrosine kinase inhibitors (EGFR TKI) provide significant clinical
benefit in patients with advanced EGFR-mutant (EGFRm + ) non–small cell lung cancer (NSCLC)…

Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom

GJ Hughes, E Fearnhill, D Dunn, SJ Lycett… - PLoS …, 2009 - journals.plos.org
The heterosexual risk group has become the largest HIV infected group in the United Kingdom
during the last 10 years, but little is known of the network structure and dynamics of viral …

[BOOK][B] The study of plant disease epidemics

LV Madden, G Hughes, F Van Den Bosch - 2007 - repository.rothamsted.ac.uk
Plant disease epidemics continue to impact a world increasingly concerned with the
quantity and quality of food supply. This useful reference and textbook provides a detailed …

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration

…, JO Curwen, HL Musgrove, GA Graham, GD Hughes… - Cancer research, 2002 - AACR
ZD6474 [N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine]is
a potent, po active, low molecular weight inhibitor of kinase insert domain-…

Regional and cellular gene expression changes in human Huntington's disease brain

…, A Kuhn, T Sengstag, G Hughes… - Human molecular …, 2006 - academic.oup.com
Huntington's disease (HD) pathology is well understood at a histological level but a comprehensive
molecular analysis of the effect of the disease in the human brain has not previously …

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity

…, P Sini, D James, Z Howard, P Dudley, G Hughes… - Cancer research, 2010 - AACR
The mammalian target of rapamycin (mTOR) kinase forms two multiprotein complexes,
mTORC1 and mTORC2, which regulate cell growth, cell survival, and autophagy. Allosteric …

[HTML][HTML] Overall survival with ribociclib plus endocrine therapy in breast cancer

…, KH Jung, A Chakravartty, G Hughes… - New England journal …, 2019 - Mass Medical Soc
Background An earlier analysis of this phase 3 trial showed that the addition of a cyclin-dependent
kinase 4 and 6 (CDK4/6) inhibitor to endocrine therapy provided a greater benefit …

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

…, N El-Saghir, MC Liu, G Carlson, G Hughes… - The lancet …, 2018 - thelancet.com
Background In MONALEESA-2, ribociclib plus letrozole showed improved progression-free
survival compared with letrozole alone as first-line treatment for postmenopausal patients …